Hormonal Contraceptive Market Drivers and Opportunities - 2031
The Hormonal Contraceptive Market is expected to register a CAGR of 4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Hormonal Contraceptive Market is a developing market due to continuous advancements in contraceptive technologies, rising awareness about reproductive health, and a greater demand for effective family planning options. Segmentation: Methods-Oral, Injectable, Transdermal, Intrauterine methods. These end users include hospitals, clinics, pharmacies, and online retail. The report deals in-depth with the key regional markets: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, underlining variations across regions with regard to adoption rates and cultural mores on contraception. Drivers, especially increasing access to reproductive health services and innovative product launches, are set against challenges related to regulatory hurdles.
Purpose of the ReportThe report Hormonal Contraceptive Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Hormonal Contraceptive Market Segmentation
Method- Combined Oral Contraceptives
- Oral Contraceptives
- Implanted Contraceptives
- Injected Contraceptives
- Intrauterine
- Transdermal Patch
- Vaginal Ring
- Androgens
- Estrogens
- Progestogens
- Gonadotropins
- Antiandrogens
- Others
- Hospitals
- Homecare
- Gynecology Centers
- Clinics
- Ambulatory Surgical Centers
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Hormonal Contraceptive Market Growth Drivers- Awareness and education on reproductive health: Several leading factors influence the market of hormonal contraceptives. Increasing awareness and education on reproductive health and family planning raise the demand for effective contraceptive methods. Government initiatives and health organizations promote access to contraceptives, especially in developing regions, thereby increasing this awareness. The rising number of unplanned pregnancies and sexually transmitted infections demands the need for reliable contraceptive options.
- New formulations and modes of delivery: New formulations like the patch, implant, and LARCs, have been developed with the facilitation of technological advances that improve user convenience and effectiveness. Furthermore, social trends toward the empowerment of women and reproductive autonomy also create an impetus for the demand for hormonal contraceptives.
- Expanding range of products tailored to various demographics: These products include those with specific health concerns or lifestyle preferences. This is supported by the increased trend in online pharmacies and telehealth services, which include hormonal contraceptives, therefore improving adherence to a patient's course of medication. In the meantime, ongoing studies concerning health benefits from hormonal contraceptives-the reduced risks of certain types of cancers and improvement in menstrual health raise their appeal among consumers, thus contributing to market growth.
- Demand for Hormonal Contraceptives: Strong growth is perceived in the hormonal contraceptive market due to numerous driving forces. Among all, growing awareness and education regarding reproductive health and family planning come first. Government and non-government organizations encourage better access to contraceptive options; hence, more adoption rates are resulting.
- Broad Social Change: The rising number of unplanned pregnancies and sexually transmitted infection cases implies that there is an urgent need for effective contraception methods, hence increasing demand for hormonal contraceptives. In addition, continuous technological growth has boosted the market due to new formulations and delivery systems that include transdermal patches, implants, and LARCS, which ensure convenience and efficacy to users.
The increasing demand for hormonal contraceptives is partly due to broad social changes; there is more attention to the empowerment of women and their reproductive rights. This has allowed a wider acceptance of the various methods of contraception, thus providing a choice for women in their reproductive health.
- Improved Accessibility due to E-commerce: The market is becoming more attractive, with the introduction of new products aimed at increasingly heterogeneous demographics that might have some health concerns. Accessibility is also growing through the use of online pharmacies and telehealth services, making access to contraceptives easier for consumers. Aggregately, these factors drive significant growth in the hormonal contraceptive market.
- Investment into R&D: In the realm of hormonal contraception, opportunities are huge-in fact, huge for both investors and companies. Growing demand for LARCs opens much greater avenues for growth, as consumers increasingly look for options that will be effective yet require less maintenance. To further improve user experience and efficacy, an ongoing research pipeline into new formulations and delivery methods has been developed, including but not limited to subdermal implants and innovative IUDs.
- Personalised Medicines: The rising focus on personalized medicine also extends avenues to personalized contraceptive products that meet specific health needs and lifestyle decisions of individual patients. This may lead to increased patient compliance and satisfaction, therefore enhancing sales.
- Advanced Technology Integration: Technological innovation, particularly in the fields of digital health and telemedicine, is yet another avenue for companies. In this regard, companies can develop apps and web portals that will help facilitate access to hormonal contraceptives, thus enabling increased patient engagement and education.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Hormonal Contraceptive Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Hormonal Contraceptive Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Amgen, Bayer Healthcare Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Inc, Novartis AG, Pfizer, Inc, Piramal Healthcare Limited, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries are key players in this market
The hormonal contraceptive market is trending towards long-acting reversible contraceptives, personalized options, digital health integration, eco-friendly products, and greater acceptance of diverse methods, reflecting evolving societal attitudes and enhancing accessibility.
The market is expected to register a CAGR of 4% during 2023-2031
Key drivers of the hormonal contraceptive market include increased awareness of reproductive health, rising demand for effective methods, technological advancements, societal shifts towards women’s empowerment, and improved accessibility through online pharmacies and telehealth services.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hormonal Contraceptive Market - By Method
1.3.2 Hormonal Contraceptive Market - By Hormones
1.3.3 Hormonal Contraceptive Market - By End User
1.3.4 Hormonal Contraceptive Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HORMONAL CONTRACEPTIVE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HORMONAL CONTRACEPTIVE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HORMONAL CONTRACEPTIVE MARKET - GLOBAL MARKET ANALYSIS
6.1. HORMONAL CONTRACEPTIVE - GLOBAL MARKET OVERVIEW
6.2. HORMONAL CONTRACEPTIVE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2028 - METHOD
7.1. OVERVIEW
7.2. METHOD MARKET FORECASTS AND ANALYSIS
7.3. COMBINED ORAL CONTRACEPTIVES
7.3.1. Overview
7.3.2. Combined Oral Contraceptives Market Forecast and Analysis
7.4. ORAL CONTRACEPTIVES
7.4.1. Overview
7.4.2. Oral Contraceptives Market Forecast and Analysis
7.5. IMPLANTED CONTRACEPTIVES
7.5.1. Overview
7.5.2. Implanted Contraceptives Market Forecast and Analysis
7.6. INJECTED CONTRACEPTIVES
7.6.1. Overview
7.6.2. Injected Contraceptives Market Forecast and Analysis
7.7. INTRAUTERINE
7.7.1. Overview
7.7.2. Intrauterine Market Forecast and Analysis
7.8. TRANSDERMAL PATCH
7.8.1. Overview
7.8.2. Transdermal Patch Market Forecast and Analysis
7.9. VAGINAL RING
7.9.1. Overview
7.9.2. Vaginal Ring Market Forecast and Analysis
8. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2028 - HORMONES
8.1. OVERVIEW
8.2. HORMONES MARKET FORECASTS AND ANALYSIS
8.3. ANDROGENS
8.3.1. Overview
8.3.2. Androgens Market Forecast and Analysis
8.4. ESTROGENS
8.4.1. Overview
8.4.2. Estrogens Market Forecast and Analysis
8.5. PROGESTOGENS
8.5.1. Overview
8.5.2. Progestogens Market Forecast and Analysis
8.6. GONADOTROPINS
8.6.1. Overview
8.6.2. Gonadotropins Market Forecast and Analysis
8.7. ANTIANDROGENS
8.7.1. Overview
8.7.2. Antiandrogens Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. HORMONAL CONTRACEPTIVE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. HOMECARE
9.4.1. Overview
9.4.2. Homecare Market Forecast and Analysis
9.5. GYNECOLOGY CENTERS
9.5.1. Overview
9.5.2. Gynecology Centers Market Forecast and Analysis
9.6. CLINICS
9.6.1. Overview
9.6.2. Clinics Market Forecast and Analysis
9.7. AMBULATORY SURGICAL CENTERS
9.7.1. Overview
9.7.2. Ambulatory Surgical Centers Market Forecast and Analysis
10. HORMONAL CONTRACEPTIVE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hormonal Contraceptive Market Overview
10.1.2 North America Hormonal Contraceptive Market Forecasts and Analysis
10.1.3 North America Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.1.4 North America Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.1.5 North America Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.1.6 North America Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hormonal Contraceptive Market
10.1.6.1.1 United States Hormonal Contraceptive Market by Method
10.1.6.1.2 United States Hormonal Contraceptive Market by Hormones
10.1.6.1.3 United States Hormonal Contraceptive Market by End User
10.1.6.2 Canada Hormonal Contraceptive Market
10.1.6.2.1 Canada Hormonal Contraceptive Market by Method
10.1.6.2.2 Canada Hormonal Contraceptive Market by Hormones
10.1.6.2.3 Canada Hormonal Contraceptive Market by End User
10.1.6.3 Mexico Hormonal Contraceptive Market
10.1.6.3.1 Mexico Hormonal Contraceptive Market by Method
10.1.6.3.2 Mexico Hormonal Contraceptive Market by Hormones
10.1.6.3.3 Mexico Hormonal Contraceptive Market by End User
10.1.6.4 US Hormonal Contraceptive Market
10.1.6.4.1 US Hormonal Contraceptive Market by Method
10.1.6.4.2 US Hormonal Contraceptive Market by Hormones
10.1.6.4.3 US Hormonal Contraceptive Market by End User
10.2. EUROPE
10.2.1 Europe Hormonal Contraceptive Market Overview
10.2.2 Europe Hormonal Contraceptive Market Forecasts and Analysis
10.2.3 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.2.4 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.2.5 Europe Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.2.6 Europe Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hormonal Contraceptive Market
10.2.6.1.1 Germany Hormonal Contraceptive Market by Method
10.2.6.1.2 Germany Hormonal Contraceptive Market by Hormones
10.2.6.1.3 Germany Hormonal Contraceptive Market by End User
10.2.6.2 France Hormonal Contraceptive Market
10.2.6.2.1 France Hormonal Contraceptive Market by Method
10.2.6.2.2 France Hormonal Contraceptive Market by Hormones
10.2.6.2.3 France Hormonal Contraceptive Market by End User
10.2.6.3 Italy Hormonal Contraceptive Market
10.2.6.3.1 Italy Hormonal Contraceptive Market by Method
10.2.6.3.2 Italy Hormonal Contraceptive Market by Hormones
10.2.6.3.3 Italy Hormonal Contraceptive Market by End User
10.2.6.4 Spain Hormonal Contraceptive Market
10.2.6.4.1 Spain Hormonal Contraceptive Market by Method
10.2.6.4.2 Spain Hormonal Contraceptive Market by Hormones
10.2.6.4.3 Spain Hormonal Contraceptive Market by End User
10.2.6.5 United Kingdom Hormonal Contraceptive Market
10.2.6.5.1 United Kingdom Hormonal Contraceptive Market by Method
10.2.6.5.2 United Kingdom Hormonal Contraceptive Market by Hormones
10.2.6.5.3 United Kingdom Hormonal Contraceptive Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hormonal Contraceptive Market Overview
10.3.2 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis
10.3.3 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.3.4 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.3.5 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hormonal Contraceptive Market
10.3.6.1.1 Australia Hormonal Contraceptive Market by Method
10.3.6.1.2 Australia Hormonal Contraceptive Market by Hormones
10.3.6.1.3 Australia Hormonal Contraceptive Market by End User
10.3.6.2 China Hormonal Contraceptive Market
10.3.6.2.1 China Hormonal Contraceptive Market by Method
10.3.6.2.2 China Hormonal Contraceptive Market by Hormones
10.3.6.2.3 China Hormonal Contraceptive Market by End User
10.3.6.3 India Hormonal Contraceptive Market
10.3.6.3.1 India Hormonal Contraceptive Market by Method
10.3.6.3.2 India Hormonal Contraceptive Market by Hormones
10.3.6.3.3 India Hormonal Contraceptive Market by End User
10.3.6.4 Japan Hormonal Contraceptive Market
10.3.6.4.1 Japan Hormonal Contraceptive Market by Method
10.3.6.4.2 Japan Hormonal Contraceptive Market by Hormones
10.3.6.4.3 Japan Hormonal Contraceptive Market by End User
10.3.6.5 South Korea Hormonal Contraceptive Market
10.3.6.5.1 South Korea Hormonal Contraceptive Market by Method
10.3.6.5.2 South Korea Hormonal Contraceptive Market by Hormones
10.3.6.5.3 South Korea Hormonal Contraceptive Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hormonal Contraceptive Market Overview
10.4.2 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis
10.4.3 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.4.4 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.4.5 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hormonal Contraceptive Market
10.4.6.1.1 South Africa Hormonal Contraceptive Market by Method
10.4.6.1.2 South Africa Hormonal Contraceptive Market by Hormones
10.4.6.1.3 South Africa Hormonal Contraceptive Market by End User
10.4.6.2 Saudi Arabia Hormonal Contraceptive Market
10.4.6.2.1 Saudi Arabia Hormonal Contraceptive Market by Method
10.4.6.2.2 Saudi Arabia Hormonal Contraceptive Market by Hormones
10.4.6.2.3 Saudi Arabia Hormonal Contraceptive Market by End User
10.4.6.3 U.A.E Hormonal Contraceptive Market
10.4.6.3.1 U.A.E Hormonal Contraceptive Market by Method
10.4.6.3.2 U.A.E Hormonal Contraceptive Market by Hormones
10.4.6.3.3 U.A.E Hormonal Contraceptive Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hormonal Contraceptive Market Overview
10.5.2 South and Central America Hormonal Contraceptive Market Forecasts and Analysis
10.5.3 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Method
10.5.4 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Hormones
10.5.5 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hormonal Contraceptive Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hormonal Contraceptive Market
10.5.6.1.1 Brazil Hormonal Contraceptive Market by Method
10.5.6.1.2 Brazil Hormonal Contraceptive Market by Hormones
10.5.6.1.3 Brazil Hormonal Contraceptive Market by End User
10.5.6.2 Argentina Hormonal Contraceptive Market
10.5.6.2.1 Argentina Hormonal Contraceptive Market by Method
10.5.6.2.2 Argentina Hormonal Contraceptive Market by Hormones
10.5.6.2.3 Argentina Hormonal Contraceptive Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HORMONAL CONTRACEPTIVE MARKET, KEY COMPANY PROFILES
12.1. AMGEN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER HEALTHCARE PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CIPLA LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLENMARK PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. LUPIN PHARMACEUTICALS, INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PIRAMAL HEALTHCARE LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUN PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
- Amgen
- Bayer Healthcare Pharmaceuticals
- Cipla Limited
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals, Inc
- Novartis AG
- Pfizer, Inc
- Piramal Healthcare Limited
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For